0001225208-16-026016.txt : 20160210 0001225208-16-026016.hdr.sgml : 20160210 20160210174519 ACCESSION NUMBER: 0001225208-16-026016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160208 FILED AS OF DATE: 20160210 DATE AS OF CHANGE: 20160210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeFord John A CENTRAL INDEX KEY: 0001403373 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 161406936 MAIL ADDRESS: STREET 1: C R BARD INC STREET 2: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0306 4 2016-02-08 0000009892 BARD C R INC /NJ/ BCR 0001403373 DeFord John A C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Sr. VP Sci Tech and Clin Afrs Common Stock 2016-02-08 4 F 0 1529.0000 179.8050 D 22116.8952 D Common Stock 2016-02-09 4 S 0 3407.0000 180.6158 D 18709.8952 D Common Stock 57.8090 I 401(k) Plan Shares withheld to pay taxes upon vesting of restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program. Includes 0.0690 shares acquired under the Company's Dividend Reinvestment Plan from November 6, 2015 to February 5, 2016. Includes 0.010 shares acquired under the Company's Employee Stock Purchase Plan as of February 5, 2016. Sales are pursuant to a previously disclosed 10b5-1 plan. Represents the weighted average sales price for price increments ranging from $180.26 to $181.24. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Includes 2.935 shares acquired under the Company's 401(k) Plan from November 7, 2015 to February 5, 2016. Myra McGinley, Attorney-in-Fact 2016-02-10